Skip to main content

Contrast specific imaging in the detection and localization of prostate cancer

World Journal of Urology volume 22, pages 346–350 (2004)Cite this article

Abstract

Prostate cancer (PCa) is the most common cancer in elderly men and is one of the most important causes of death from cancer in men. The diagnosis of PCa is based on a combination of digital rectal examination, PSA and transrectal ultrasound (TRUS). However, this combination does not reach the accuracy of detection and localization necessary for proper decisions on treatment methods. Therefore, biopsies are performed in all cases for which the suspicion of PCa is raised. Even with biopsies, staging and grading of PCa is far from optimal. More accurate imaging is necessary to improve the biopsy sampling, the goals being to replace systematic biopsies by a targeted approach and to improve staging and grading of PCa. Ultrasound imaging of the prostate remains the first choice of imaging to visualize the prostate, however, gray-scale ultrasound imaging has an accuracy of about 50–60% for the detection of PCa and TRUS used for local staging has an even lower accuracy. The development of PCa is associated with changes in the metabolism of tumor cells, and therefore with changes in the blood perfusion of the involved tissue. This paper focuses on contrast specific imaging techniques to visualize these changes in blood perfusion. Techniques such as color and power Doppler imaging, and contrast enhanced imaging techniques using color and power Doppler, harmonic imaging and intermittent imaging are discussed.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Aarnink RG, Beerlage HP, de la Rosette JJ, Debruyne FM, Wijkstra H (1999) Contrast angiosonography: a technology to improve Doppler ultrasound examinations of the prostate. Eur Urol 35:9–20

    Google Scholar 

  2. American Cancer Society (2004) Cancer facts and figures. American Cancer Society, Atlanta

  3. Basude R, Wheatley MA (2001) Generation of ultraharmonics in surfactant based ultrasound contrast agents: use and advantages. Ultrasonics 39:437–444

    Google Scholar 

  4. Bogers HA, Sedelaar JPM, Beerlage HP et al. (1999) Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54:97–104

    Google Scholar 

  5. Borre M, Offersen BV, Nerstrom B, Overgaard J (1998) Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 78:940–944

    Google Scholar 

  6. Bouakaz A, Frigstad S, Ten Cate FJ, De Jong N (2002) Super harmonic imaging: a new imaging technique for improved contrast detection. Ultrasound Med Biol 28:59–68

    Google Scholar 

  7. Bree RL (1997) The role of color Doppler and staging biopsies in prostate cancer detection. Urology 49:31–34

    Google Scholar 

  8. Bustamante E, Morris HP, Pedersen PL (1981) Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem 256:8699–8704

    Google Scholar 

  9. Chang JJ, Shinohara K, Bhargava V, Presti JCJr (1998) Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 160:2111–2114

    Google Scholar 

  10. Chomas JE, Dayton P, Allen J, Morgan K, Ferrara KW (2001). Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control 48:232–248

    Google Scholar 

  11. Cornud F, Belin X, Piron D et al. (1997) Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 49:709–715

    Google Scholar 

  12. Cornud F, Hamida K, Flam T et al. (2000) Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol 175:1161–1168

    Google Scholar 

  13. Cvetkovic D, Movsas B, Dicker AP et al. (2001) Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. Urology 57:821–825

    Google Scholar 

  14. Dang CV, Semenza GL (1999). Oncogenic alterations of metabolism. Trends Biochem Sci 24:68–72

    Google Scholar 

  15. Dayton PA, Morgan KE, Klibanov AL, Brandenburger GH, Ferrara KW (1999) Optical and acoustical observations of the effects of ultrasound on contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control ; 46:220–232

    Google Scholar 

  16. Djavan B, Zlotta A, Kratzik C et al. (1999) PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 L. Urology 54:517–522

    Google Scholar 

  17. Djavan B, Zlotta A, Remzi M et al. (2000) Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 163:1144–1148; discussion 8–9

    Google Scholar 

  18. Djavan B, Mazal P, Zlotta A et al. (2001) Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Prostate 47:111–117

    Google Scholar 

  19. Eckersley R, Cosgrove D, Blomley M, Hashimoto H (1998) Functional imaging of tissue response to bolus injection of ultrasound contrast agent. Proceedings of the IEEE Ultrasonics Symposium, Sendai, Japan, 1998, pp 1779–1782

  20. Egawa S, Wheeler TM, Greene DR, Scardino PT (1992) Unusual hyperechoic appearance of prostate cancer on transrectal ultrasonography. Br J Urol 69:169–174

    Google Scholar 

  21. Engelbrecht MR, Barentsz JO, Jager GJ et al. (2000) Prostate cancer staging using imaging. BJU Int 86:123–134

    Google Scholar 

  22. Franco OE, Arima K, Yanagawa M, Kawamura J (2000) The usefulness of power Doppler ultrasonography for diagnosing prostate cancer: histological correlation of each biopsy site. BJU Int 85:1049–1052

    Google Scholar 

  23. Frauscher F, Klauser A, Volgger H et al. (2002) Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167:1648–1652

    Google Scholar 

  24. Goossen TEB, Sedelaar JPM, De la Rosette JJMCH, Van Leenders GJLH, Wijkstra H (2002) The value of dynamic contrast enhanced power Doppler ultrasound in the localization of prostate carcinoma. abstract 355, Eur Urol [Suppl 1]1:91

  25. Halpern EJ, Verkh L, Forsberg F et al. (2000) Initial experience with contrast-enhanced sonography of the prostate. AJR Am J Roentgenol 174:1575–1580

    Google Scholar 

  26. Halpern EJ, Strup SE (2000) Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol ; 174:623–637

    Google Scholar 

  27. Halpern EJ, Rosenberg M, Gomella LG (2001) Prostate cancer: contrast-enhanced us for detection. Radiology 219:219–225

    Google Scholar 

  28. Hendrikx AJ, De la Rosette JJ, Van Helvoort-van Dommelen CA et al. (1990) Histological analysis of ultrasonic images of the prostate: an accurate technique. Ultrasound Med Biol 16:667–674

    Google Scholar 

  29. Hope Simpson D, Chin CT, Burns PN (1999) Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 46:372–382

    Google Scholar 

  30. Kamiyama N, Moriyasu F, Mine Y, Goto Y (1999) Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems. Ultrasound Med Biol 25:411–420

    Google Scholar 

  31. Mathupala SP, Rempel A, Pedersen PL (2001) Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem 276:43407–43412

    Google Scholar 

  32. Mitchell ID, Croal BL, Dickie A, Cohen NP, Ross I (2001) A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer. J Urol 165:1549–1553

    Google Scholar 

  33. Movsas B, Chapman JD, Horwitz EM et al. (1999) Hypoxic regions exist in human prostate carcinoma. Urology 53:11–18

    Google Scholar 

  34. Movsas B, Chapman JD, Greenberg RE et al. (2000) Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study. Cancer 89:2018–2024

    Google Scholar 

  35. Norberg M, Egevad L, Holmberg L et al. (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50:562–566

    Google Scholar 

  36. Okihara K, Kojima M, Nakanouchi T, Okada K, Miki T (2000) Transrectal power Doppler imaging in the detection of prostate cancer. BJU Int 85:1053–1057

    Google Scholar 

  37. Perrotti M, Pantuck A, Rabbani F, Israeli RS, Weiss RE (1999) Review of staging modalities in clinically localized prostate cancer. Urology 54:208–214

    Google Scholar 

  38. Roehrborn CG, Pickens GJ, Sanders JS (1996). Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate-specific antigen levels. Urology 47:347–352

    Google Scholar 

  39. Rubin MA, Buyyounouski M, Bagiella E et al. (1999) Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. Urology 53:542–547

    Google Scholar 

  40. Sedelaar JP, Van Leenders GJ, Hulsbergen-Van De Kaa CA et al. (2001) Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol 40:285–293

    Google Scholar 

  41. Siegal JA, Yu E, Brawer MK (1995) Topography of neovascularity in human prostate carcinoma. Cancer 75:2545–2551

    Google Scholar 

  42. Silberman MA, Partin AW, Veltri RW, Epstein JI (1997) Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer 79:772–779

    Google Scholar 

  43. Singh G, Lakkis CL, Laucirica R, Epner DE (1999) Regulation of prostate cancer cell division by glucose. J Cell Physiol ; 180:431–438

    Google Scholar 

  44. Shigeno K, Igawa M, Shiina H, Wada H, Yoneda T (2000) The role of colour Doppler ultrasonography in detecting prostate cancer. BJU Int 86:229–233

    Google Scholar 

  45. Shinohara K, Wheeler TM, Scardino PT (1989) The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 142:76–82

    Google Scholar 

  46. Tiemann K, Pohl C, Schlosser T et al. (2000) Stimulated acoustic emission: pseudo-Doppler shifts seen during the destruction of nonmoving microbubbles. Ultrasound Med Biol 26:1161–1167

    Google Scholar 

  47. Unal D, Sedelaar JP, Aarnink RG et al. (2000) Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer. BJU Int 86:58–64

    Google Scholar 

  48. Wilkinson BA, Hamdy FC (2001) State-of-the-art staging in prostate cancer. BJU Int 87:423–430

    Google Scholar 

Download references

Author information

Affiliations

  1. Department of Urology (G4-162), Academic Medical Center, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands

    Hessel Wijkstra, Margot H. Wink & Jean J. M. C. H. de la Rosette

Authors
  1. Hessel Wijkstra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margot H. Wink
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean J. M. C. H. de la Rosette
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hessel Wijkstra.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wijkstra, H., Wink, M.H. & de la Rosette, J.J.M.C.H. Contrast specific imaging in the detection and localization of prostate cancer. World J Urol 22, 346–350 (2004). https://doi.org/10.1007/s00345-004-0419-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-004-0419-7

Keywords

  • Ultrasound
  • Contrast agent
  • Prostate cancer
  • Perfusion imaging